Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Recordati

Tracked across 1 events · 13 articles · First seen Jan 29, 2026 · Last active Jan 29, 2026

Sentiment
70
Attention
4
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 70
Business
Recordati entered into a collaboration and license agreement with Moderna to develop and commercialize mRNA-3927 for propionic acidemia. Recordati will lead global commercialization efforts if the product is approved, expanding its rare disease portfolio. The company will pay Moderna an upfront fee and potential milestones, but does not expect significant EBITDA impact before launch.
Jan 29, 2026 · 13 articles
Moderna partner Recordati Moderna and Recordati are partners in the development and commercialization of m
Rob Koremans CEO Recordati Rob Koremans is the Chief Executive Officer of Recordati.
NEWSDESK
Track Recordati live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.